-
1
-
-
0033966945
-
Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs
-
Segal JB, McNamara RL, Miller MR, Kim N, Goodman SN, Powe NR etal. Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med 2000; 15: 56-67.
-
(2000)
J Gen Intern Med
, vol.15
, pp. 56-67
-
-
Segal, J.B.1
McNamara, R.L.2
Miller, M.R.3
Kim, N.4
Goodman, S.N.5
Powe, N.R.6
-
2
-
-
33747052359
-
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
-
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP etal. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-25.
-
(2006)
Circulation
, vol.114
, pp. 119-125
-
-
Miyasaka, Y.1
Barnes, M.E.2
Gersh, B.J.3
Cha, S.S.4
Bailey, K.R.5
Abhayaratna, W.P.6
-
3
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation
-
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV etal. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation. JAMA 2001; 285: 2370-5.
-
(2001)
JAMA
, vol.285
, pp. 2370-2375
-
-
Go, A.S.1
Hylek, E.M.2
Phillips, K.A.3
Chang, Y.4
Henault, L.E.5
Selby, J.V.6
-
4
-
-
0030474964
-
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
-
Beyth RJ, Antani MR, Covinsky KE, Miller DG, Chren MM, Quinn LM etal. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med 1996; 11: 721-8.
-
(1996)
J Gen Intern Med
, vol.11
, pp. 721-728
-
-
Beyth, R.J.1
Antani, M.R.2
Covinsky, K.E.3
Miller, D.G.4
Chren, M.M.5
Quinn, L.M.6
-
5
-
-
9744278991
-
Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?
-
Young L, Ockelford P, Harper P. Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary? Intern Med J 2004; 34: 639-41.
-
(2004)
Intern Med J
, vol.34
, pp. 639-641
-
-
Young, L.1
Ockelford, P.2
Harper, P.3
-
6
-
-
31844453122
-
Self-monitoring of oral anticoagulation: a systematic review andmeta-analysis
-
Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review andmeta-analysis. Lancet 2006; 367: 404-11.
-
(2006)
Lancet
, vol.367
, pp. 404-411
-
-
Heneghan, C.1
Alonso-Coello, P.2
Garcia-Alamino, J.M.3
Perera, R.4
Meats, E.5
Glasziou, P.6
-
7
-
-
12744254919
-
Review
-
Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring
-
Gardiner C, Williams K, Mackie IJ, Machin SJ, Cohen H. Review. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol 2005; 128: 242-7.
-
(2005)
Br J Haematol
, vol.128
, pp. 242-247
-
-
Gardiner, C.1
Williams, K.2
Mackie, I.J.3
Machin, S.J.4
Cohen, H.5
-
9
-
-
33644862002
-
Guidelines on oral anticoagulation (warfarin): third edition - 2005 update; British Committee for Standards in Haematology
-
Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition - 2005 update; British Committee for Standards in Haematology. Br J Haematol 2006; 132: 277-85.
-
(2006)
Br J Haematol
, vol.132
, pp. 277-285
-
-
Baglin, T.P.1
Keeling, D.M.2
Watson, H.G.3
-
10
-
-
14144250885
-
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism
-
Veeger NJ, Piersma-Wichers M, Tijssen JG, Hillege HL, van der Meer J. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. Br J Haematol 2005; 128: 513-19.
-
(2005)
Br J Haematol
, vol.128
, pp. 513-519
-
-
Veeger, N.J.1
Piersma-Wichers, M.2
Tijssen, J.G.3
Hillege, H.L.4
van der Meer, J.5
-
11
-
-
70349657518
-
Anticoagulation control and prediction of adverse events in patients with atrial fibrillation a systematic review
-
Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P etal. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation a systematic review. Circ Cardiovasc Qual Outcomes 2008; 1: 84-91.
-
(2008)
Circ Cardiovasc Qual Outcomes
, vol.1
, pp. 84-91
-
-
Wan, Y.1
Heneghan, C.2
Perera, R.3
Roberts, N.4
Hollowell, J.5
Glasziou, P.6
-
12
-
-
0027232447
-
Prospective comparative study of computer programs used for management of warfarin
-
Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol 1993; 46: 299-303.
-
(1993)
J Clin Pathol
, vol.46
, pp. 299-303
-
-
Poller, L.1
Wright, D.2
Rowlands, M.3
-
13
-
-
48449101811
-
Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation
-
O'Shea SI, Arcasoy MO, Samsa G, Cumming SE, Thames EH, Surwit RS etal. Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation. J Thromb Thrombolyisis 2008; 26: 14-21.
-
(2008)
J Thromb Thrombolyisis
, vol.26
, pp. 14-21
-
-
O'Shea, S.I.1
Arcasoy, M.O.2
Samsa, G.3
Cumming, S.E.4
Thames, E.H.5
Surwit, R.S.6
-
14
-
-
67949094412
-
Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system
-
Ryan F, Byrne S, O'Shea S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. J Thromb Haemostas 2009; 7: 1284-90.
-
(2009)
J Thromb Haemostas
, vol.7
, pp. 1284-1290
-
-
Ryan, F.1
Byrne, S.2
O'Shea, S.3
-
15
-
-
0034107497
-
Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management
-
Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000; 9: 283-92.
-
(2000)
J Thromb Thrombolysis
, vol.9
, pp. 283-292
-
-
Samsa, G.P.1
Matchar, D.B.2
-
16
-
-
0031937723
-
Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease
-
Suppl.
-
Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998; 5 (Suppl. 1): 19-24.
-
(1998)
J Thromb Thrombolysis
, vol.5
, Issue.1
, pp. 19-24
-
-
Horstkotte, D.1
Piper, C.2
Wiemer, M.3
-
17
-
-
33745662843
-
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy
-
Regier DA, Sunderji R, Lynd LD, Gin K, Marra CA. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. Can Med Assoc J 2006; 174: 1847-52.
-
(2006)
Can Med Assoc J
, vol.174
, pp. 1847-1852
-
-
Regier, D.A.1
Sunderji, R.2
Lynd, L.D.3
Gin, K.4
Marra, C.A.5
|